BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38235319)

  • 1. Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy.
    Zheng Y; Lebid A; Chung L; Fu J; Wang X; Otrocol A; Zarif JC; Yu H; Llosa NJ; Pardoll DM
    Oncoimmunology; 2024; 13(1):2297503. PubMed ID: 38235319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
    Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
    J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
    Schmidt A; Éliás S; Joshi RN; Tegnér J
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4
    Chen FY; Geng CA; Chou CK; Zheng JB; Yang Y; Wang YF; Li TZ; Li P; Chen JJ; Chen X
    Phytomedicine; 2022 Dec; 107():154482. PubMed ID: 36202057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
    Centuori SM; Trad M; LaCasse CJ; Alizadeh D; Larmonier CB; Hanke NT; Kartchner J; Janikashvili N; Bonnotte B; Larmonier N; Katsanis E
    J Leukoc Biol; 2012 Nov; 92(5):987-97. PubMed ID: 22891289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.
    Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA
    PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid promotes TGF-β-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus.
    Lu L; Ma J; Li Z; Lan Q; Chen M; Liu Y; Xia Z; Wang J; Han Y; Shi W; Quesniaux V; Ryffel B; Brand D; Li B; Liu Z; Zheng SG
    PLoS One; 2011; 6(9):e24590. PubMed ID: 21931768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7.
    Vestal KA; Kattamuri C; Koyiloth M; Ongaro L; Howard JA; Deaton AM; Ticau S; Dubey A; Bernard DJ; Thompson TB
    Biochem J; 2024 Apr; 481(7):547-564. PubMed ID: 38533769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
    De Martino M; Daviaud C; Diamond JM; Kraynak J; Alard A; Formenti SC; Miller LD; Demaria S; Vanpouille-Box C
    Cancer Immunol Res; 2021 Jan; 9(1):89-102. PubMed ID: 33093219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.
    Ni X; Tao J; Barbi J; Chen Q; Park BV; Li Z; Zhang N; Lebid A; Ramaswamy A; Wei P; Zheng Y; Zhang X; Wu X; Vignali P; Yang CP; Li H; Pardoll D; Lu L; Pan D; Pan F
    Cancer Discov; 2018 Aug; 8(8):1026-1043. PubMed ID: 29907586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients.
    García EM; Galicia-Carreón J; Novak N
    Int Arch Allergy Immunol; 2020; 181(5):353-356. PubMed ID: 32160611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2.
    Knosp CA; Schiering C; Spence S; Carroll HP; Nel HJ; Osbourn M; Jackson R; Lyubomska O; Malissen B; Ingram R; Fitzgerald DC; Powrie F; Fallon PG; Johnston JA; Kissenpfennig A
    J Immunol; 2013 Apr; 190(7):3235-45. PubMed ID: 23455506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin-A impedes the establishment of CD4
    Morianos I; Tsitsopoulou A; Potaris K; Valakos D; Fari O; Vatsellas G; Bostantzoglou C; Photiades A; Gaga M; Xanthou G; Semitekolou M
    J Exp Clin Cancer Res; 2021 Sep; 40(1):295. PubMed ID: 34548096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.